home All News open_in_new Full Article

BioNTech výrazne znížil stratu v 3. štvrťroku, tržby prekonali očakávania vďaka spolupráci s BMS

Nemecká farmaceutická spoločnosť BioNTech oznámila za 3. štvrťrok výrazné zníženie straty. Výsledky podporil rast tržieb nad 1,5 miliardy eur, za čím je najmä platba firmy Bristol Myers Squibb (BMS). Informovala


today 15 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 1600961605
Add Watch Country

arrow_drop_down